Related Experiment Video
Updated: Jul 5, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
The endogenous cannabinoid system modulates nicotine reward and dependence
Lisa L Merritt1, B R Martin, C Walters
1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
Summary
The endogenous cannabinoid system influences nicotine addiction. Disrupting cannabinoid receptor 1 (CB1) signaling reduces nicotine reward, while increasing endocannabinoids worsens withdrawal symptoms, suggesting CB1 antagonists may help treat tobacco dependence.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- The endogenous cannabinoid system plays a role in modulating the rewarding effects of nicotine.
- Understanding this system's interaction with nicotine is crucial for developing effective tobacco dependence treatments.
Purpose of the Study:
- To investigate the hypothesis that the endocannabinoid system modulates nicotine reward and dependence.
- To explore the specific roles of cannabinoid receptor 1 (CB1) and fatty acid amide hydrolase (FAAH) in nicotine's effects.
Main Methods:
- Utilized complementary transgenic (CB1 knockout mice) and pharmacological approaches (CB1 antagonist rimonabant, FAAH inhibition).
- Assessed nicotine reward using the conditioned place preference (CPP) paradigm.
- Evaluated nicotine withdrawal signs in various experimental models.
Main Results:
- Disruption of CB1 receptor signaling blocked nicotine reward.
- Inhibition of FAAH (increasing anandamide) enhanced nicotine CPP and exacerbated withdrawal symptoms.
- CB1 antagonism ameliorated somatic withdrawal signs, while increased endocannabinoids worsened them.
Conclusions:
- Endocannabinoids are involved in both the rewarding properties of nicotine and nicotine dependence liability.
- Modulating the endocannabinoid system, particularly through CB1 receptor antagonists, shows therapeutic potential for tobacco dependence treatment.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...